Leading the way to safer medication
 Crosscheck  Recommender

Omeprazole

Description

Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.

ATC Classification

Code
Title
Category
A02BC01
Omeprazole
A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors

Trade names

Trade name
Countries

Australia

Spain

Spain

Spain

Cyprus

Spain

Australia Austria Canada Cyprus Netherlands

Netherlands

Australia

Cyprus

United Kingdom

France

Spain

Singapore

Cyprus

Singapore

Spain

Austria

Netherlands

Spain

Singapore

Singapore

Australia

Austria

Spain

Singapore

Singapore

Singapore

Singapore

Cyprus

Australia

Spain

Netherlands

Australia

Cyprus Singapore

Spain

United States

Australia Singapore

Singapore

Singapore

Singapore

United Kingdom

Singapore

Cyprus

Singapore

Singapore

Spain

Spain

Singapore

Singapore

France

Trade names (in combination): ARTHROCOMB DICLODUO COMBI TALICIA YOSPRALA ZEGERID

Product Monographs

Monograph
Type
Country
PRILOSEC Granule for delayed-release oral suspension
MPI, US: SPL/PLR
US
OMEPRAZOLE Powder for solution for infusion
MPI, EU: SmPC
UK
OMEPRAZOLE Gastro-resistant capsules
MPI, EU: SmPC
UK